Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11

A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said on Thursday.

Reuters

Commentary: Is a second booster for COVID-19 the right choice for you?

The Food and Drug Administration and the Centers for Disease Control and Prevention recently authorized a second booster shot of the Pfizer/BioNTech and Moderna COVID-19 vaccines for those age 50 and older. The recommendation follows a study out of Israel recently published in The New England Journal of Medicine.

Chicago Tribune

Healthy young people don’t need a fourth Covid jab, says virus expert

Welsh immunologist says we'd be better off vaccinating the rest of the world to protect against new variants than giving young, healthy people a fourth shot

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

Woman claims rare reaction to Covid jab saw her 'age 20 years in three days'

Michelle Flower, from Sheffield, says she had a rare adverse reaction to having a Pfizer Covid booster in January that led to her "ageing 20 years in just three days"

Daily Mirror

Woman claims rare reaction to booster jab left her with hives and cuts ‘ageing her 20 years in three days’

The woman is adamant she is not an anti-vaxxer and is keen to make people aware of alleged risks

Wales Online

Marcus Hayes: Half-vaxxed Matisse Thybulle is a bad (and badly informed) Sixers teammate

PHILADELPHIA — The Sixers’ biggest problem used to be, they had a guy who wouldn’t take a shot.

The Philadelphia Inquirer

Woman claims her Covid booster jab has 'aged her 20 years in three days' - but still wants people to get jabbed

On the NHS website, it states that serious allergic reactions to the Covid-19 vaccines are very rare and usually occur within minutes

Manchester Evening News

Read news from The Economist, FT, and more,
with one subscription

Sixers coach Doc Rivers encouraged Matisse Thybulle to get vaccinated but continued ‘to support the kid’

PHILADELPHIA — Doc Rivers has known all season that 76ers starting wing Matisse Thybulle was not vaccinated against COVID-19. Rivers added he “encouraged [Thybulle] all year” to receive the required shot(s).

The Philadelphia Inquirer

What's Going On With Myovant Sciences Stock Today?

Myovant Sciences Ltd (NYSE: MYOV) shares are trading significantly lower Tuesday after the company and Pfizer Inc (NYSE: PFE) announced an update on the Supplemental New Drug Application for MYFEMBREE for the manag

Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

COVID vaccines: why second boosters are being offered to vulnerable people in the UK – but not young and healthy people yet

Until recently, the UK government limited a fourth dose of the COVID vaccine to people with severely weakened immune systems over the age of 16.

The Conversation

Pfizer offers $100m to buy Brisbane company behind smartphone app that diagnoses COVID-19

Pfizer offers $100 million to buy a ResApp, a company that has invented a smartphone app it says can diagnose COVID-19 by listening to someone cough.

ABC News

Matisse Thybulle Not Fully Vaccinated, Can’t Play in Toronto for First Round of Playoffs

Matisse Thybulle has only gotten one shot of the Pfizer vaccine and won’t be able to play in some of Philadelphia’s first-round games.

Sports Illustrated

Explained | Why India administers ‘precaution dose’ of COVID-19 vaccine, and not ‘booster dose’

As India gears up to administer ‘precaution doses’ of COVID-19 vaccine to eligible population above 18 years from Sunday, the debate over ‘booster’ vs ‘precaution’ doses has arisen.

The Hindu

Get all your
news in one place.

100's of premium titles.
One news app.

Asharq Al-Awsat

China's Health System Faces Raft of Challenges as Omicron Hits

China is battling its biggest spike in coronavirus cases since the start of the pandemic, with millions under lockdown and the healthcare system feeling the pressure. One of the last countries sticking to a zero-Covid strategy, China aims to stamp out every infection with strict lockdowns and by sending all…

Benzinga

Looking At Pfizer's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 47 strange trades.

Los Angeles Times

Michael Hiltzik: The anti-vaxxers' campaign against public health advocates gets scarier and more rabid

Last December, we reported on the threatening behavior of a group of anti-vaccine activists toward Kristina Lawson, the president of the Medical Board of California.

ABC News

TGA approves Pfizer COVID-19 boosters for 12-15-year-olds, final approval needed from ATAGI

The Therapeutic Goods Administration has approved the Pfizer COVID booster for people aged 12 to 15, but it will need a final tick of approval before it is made available to the cohort.

Get all your
news in one place.

100's of premium titles.
One news app.

Asharq Al-Awsat

Egypt Receives 1.5 Million COVID Vaccine Doses from US

Egypt has received 1.5 million doses of Pfizer’s coronavirus vaccine donated by the US government. Acting Health Minister Khaled Abdel Ghaffar said Egypt received 1,501,110 Pfizer COVID-19 vaccine doses gifted by the US and delivered through the COVAX initiative and in cooperation with the Vaccine Alliance (GAVI). The new batch…

Benzinga

What's Going On With Pfizer Stock Today?

Pfizer Inc (NYSE: PFE) shares are trading higher Thursday. The company announced the acquisition of ReViral for a total consideration of up to $525 million.

Benzinga

What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

Benzinga

Pfizer Beefs Up Its RSV Antiviral Portfolio With $525M ReViral Acquisition

Pfizer Inc (NYSE: PFE)

Benzinga

The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Axios

The high-stakes push to get COVID vaccines to young children

The Omicron variant and and anti-vaccine backlash are complicating the effort.

Tribune News Service

Second COVID booster shot extends protection for just a few weeks, study shows

A fourth shot of the Pfizer COVID-19 vaccine increased protection against viral infection for only four to seven weeks, according to a massive study published Tuesday.

1 … 59 60 61 62

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Centers for Disease Control and Prevention

328 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.